胃食管反流病的诊断与管理进展
胃食管反流病(GERD)是一组由胃食管反流引起或加重的综合征,主要表现为令人困扰的症状。其主要表型包括非糜烂性反流病、GERD高敏感、低级别或高级别食管炎、Barrett食管、反流性胸痛、咽喉反流和以反流为主的反流。GERD在全球常见,其流行病学与西方生活方式、肥胖和幽门螺杆菌减少相关。典型症状者发生食管腺癌的风险增加五倍,但GERD致死少见。管理原则是缓解症状并通过生活方式调整、诊断检测、药物(主要是抑制或中和胃酸分泌)和手术等组合来最小化健康风险,但通常为慢性复发性疾病,需个体化管理。虽然升级质子泵抑制剂治疗可能适用于治愈高级别食管炎,但其对其他GERD表型的适用性存疑,因为这些表型中焦虑、动力障碍、高敏感和非食管因素的调节作用可能占主导。
要点
- GERD包含多种表型,典型症状者食管腺癌风险增加五倍。
- 管理目标为缓解症状和降低健康风险,需个体化组合生活方式、药物和手术。
- 升级PPI治疗可能适用于高级别食管炎,但对其他表型效果存疑。
核心结论
- GERD是一组异质性综合征,管理需个体化,升级PPI治疗并非对所有表型有效。
研究设计与样本
- 综述,未报告系统检索范围与样本量。
主要发现
- GERD主要表型包括非糜烂性反流病、GERD高敏感、低或高级别食管炎、Barrett食管、反流性胸痛、咽喉反流和以反流为主的反流。
- GERD在全球常见,流行病学与西方生活方式、肥胖和幽门螺杆菌减少相关。
- 典型症状者发生食管腺癌的风险增加五倍,但GERD致死少见。
- GERD因患病率和慢性病程带来显著经济负担,涉及就诊、诊断、癌症监测方案和治疗。
临床怎么用
- 管理原则为缓解症状和最小化健康风险,可采用生活方式调整、诊断检测、药物(主要抑制或中和胃酸分泌)和手术的组合。
- GERD通常为慢性复发性疾病,管理需根据每个病例个体化。
- 升级质子泵抑制剂治疗可能适用于治愈高级别食管炎,但对其他GERD表型适用性存疑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gastroesophageal reflux disease (GERD) is a multifaceted disorder encompassing a family of syndromes attributable to, or exacerbated by, gastroesophageal reflux that impart morbidity, mainly through troublesome symptoms. Major GERD phenotypes are non-erosive reflux disease, GERD hypersensitivity, low or high grade esophagitis, Barrett's esophagus, reflux chest pain, laryngopharyngeal reflux, and regurgitation dominant reflux. GERD is common throughout the world, and its epidemiology is linked to the Western lifestyle, obesity, and the demise of Helicobacter pylori. Because of its prevalence and chronicity, GERD is a substantial economic burden measured in physician visits, diagnostics, cancer surveillance protocols, and therapeutics. An individual with typical symptoms has a fivefold risk of developing esophageal adenocarcinoma, but mortality from GERD is otherwise rare. The principles of management are to provide symptomatic relief and to minimize potential health risks through some combination of lifestyle modifications, diagnostic testing, pharmaceuticals (mainly to suppress or counteract gastric acid secretion), and surgery. However, it is usually a chronic recurring condition and management needs to be personalized to each case. While escalating proton pump inhibitor therapy may be pertinent to healing high grade esophagitis, its applicability to other GERD phenotypes wherein the modulating effects of anxiety, motility, hypersensitivity, and non-esophageal factors may dominate is highly questionable.
引用
- Katzka DA, Kahrilas PJ. Advances in the diagnosis and management of gastroesophageal reflux disease. BMJ. 2020. PMID: 33229333. doi:10.1136/bmj.m3786
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。